CN

Chathambil Nandanan

Active Director Director DIN 10403002
DIN 10403002 First appointment Nov 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value •••• Premium profile

About Chathambil Nandanan

Data last updated:

Chathambil Nandanan is a Director at Dr Bone Life Sciences Private Limited (since 2023). Dr Bone Life Sciences Private Limited reported revenue of ₹14.2 Lakh (FY 2025).

DIN 10403002
Primary Designation Director
First Appointment 23 Nov 2023
Oldest Company Age 2 yrs
Largest company Dr Bone Life Sciences Private Limited · ₹14.2 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Nov 20232023₹14.2 Lakh (FY 2025)Active

Board colleagues of Chathambil Nandanan

Directorship timeline

Open interactive timeline →
Dr Bone Life Sciences Private Limited
Premium access

Shareholding and investment profile for Chathambil Nandanan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chathambil Nandanan

Chathambil Nandanan currently holds 1 directorship: Dr Bone Life Sciences Private Limited (Director, since 23 Nov 2023, revenue ₹14.2 Lakh (FY 2025)).

Chathambil Nandanan was first appointed on 23 Nov 2023 as Director at Dr Bone Life Sciences Private Limited.

The current boards of Chathambil Nandanan's companies include Chiramel Jose Jinson (Dr Bone Life Sciences Private Limited), Kallupalam Mohanan Midhun (Dr Bone Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available